Augmented O-GlcNAc signaling attenuates oxidative stress and calcium overload in cardiomyocytes.
O-linked β-N-acetylglucosamine (O-GlcNAc) is an inducible, dynamically cycling and reversible post-translational modification of Ser/Thr residues of nucleocytoplasmic and mitochondrial proteins. We recently discovered that O-GlcNAcylation confers cytoprotection in the heart via attenuating the formation of mitochondrial permeability transition pore (mPTP) and the subsequent loss of mitochondrial membrane potential. Because Ca(2+) overload and reactive oxygen species (ROS) generation are prominent features of post-ischemic injury and favor mPTP formation, we ascertained whether O-GlcNAcylation mitigates mPTP formation via its effects on Ca(2+) overload and ROS generation. Subjecting neonatal rat cardiac myocytes (NRCMs, n ≥ 6 per group) to hypoxia, or mice (n ≥ 4 per group) to myocardial ischemia reduced O-GlcNAcylation, which later increased during reoxygenation/reperfusion. NRCMs (n ≥ 4 per group) infected with an adenovirus carrying nothing (control), adenoviral O-GlcNAc transferase (adds O-GlcNAc to proteins, AdOGT), adenoviral O-GlcNAcase (removes O-GlcNAc to proteins, AdOGA), vehicle or PUGNAc (blocks OGA; increases O-GlcNAc levels) were subjected to hypoxia-reoxygenation or H(2)O(2), and changes in Ca(2+) levels (via Fluo-4AM and Rhod-2AM), ROS (via DCF) and mPTP formation (via calcein-MitoTracker Red colocalization) were assessed using time-lapse fluorescence microscopy. Both OGT and OGA overexpression did not significantly (P > 0.05) alter baseline Ca(2+) or ROS levels. However, AdOGT significantly (P < 0.05) attenuated both hypoxia and oxidative stress-induced Ca(2+) overload and ROS generation. Additionally, OGA inhibition mitigated both H(2)O(2)-induced Ca(2+) overload and ROS generation. Although AdOGA exacerbated both hypoxia and H(2)O(2)-induced ROS generation, it had no effect on H(2)O(2)-induced Ca(2+) overload. We conclude that inhibition of Ca(2+) overload and ROS generation (inducers of mPTP) might be one mechanism through which O-GlcNAcylation reduces ischemia/hypoxia-mediated mPTP formation.
Ngoh
Gladys A
GA
Department of Physiology and Biophysics, Diabetes and Obesity Center, Institute of Molecular Cardiology, University of Louisville, Louisville, KY 40202, USA.
Watson
Lewis J
LJ
Facundo
Heberty T
HT
Jones
Steven P
SP
D000117:Acetylglucosamine / Q000378:metabolism*; D000818:Animals; D002118:Calcium / Q000378:metabolism*; D002478:Cells, Cultured; D006031:Glycosylation; D006861:Hydrogen Peroxide / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D033681:Mitochondrial Membrane Transport Proteins / Q000378:metabolism; D000083162:Mitochondrial Permeability Transition Pore; D032383:Myocytes, Cardiac / Q000378:metabolism*; D018384:Oxidative Stress; D051381:Rats; D017207:Rats, Sprague-Dawley; D015398:Signal Transduction
D033681:Mitochondrial Membrane Transport Proteins; D000083162:Mitochondrial Permeability Transition Pore; D006861:Hydrogen Peroxide; D002118:Calcium; D000117:Acetylglucosamine
Am J Physiol. 1998 Dec;275(6):H2300-7
9843832
J Biol Chem. 2004 Jul 16;279(29):30133-42
15138254
Biochem J. 1987 Aug 1;245(3):915-8
3117053
Shock. 2006 Jun;25(6):600-7
16721268
Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H515-23
19098112
IUBMB Life. 2001 Sep-Nov;52(3-5):255-61
11798040
Eur J Biochem. 1999 Sep;264(3):687-701
10491114
Circ Res. 2003 Aug 8;93(3):192-200
12855674
Am J Physiol Heart Circ Physiol. 2004 Jan;286(1):H276-82
12969888
Shock. 2007 Apr;27(4):402-8
17414423
Am J Med. 2000 Sep;109(4):315-23
10996583
Am J Physiol Heart Circ Physiol. 2000 Nov;279(5):H2196-201
11045953
Am J Physiol Heart Circ Physiol. 2005 Mar;288(3):H1290-5
15528225
Coron Artery Dis. 2001 Feb;12(1):37-44
11211164
Cardiovasc Res. 2007 Jan 15;73(2):288-97
16970929
J Mol Cell Cardiol. 2008 Aug;45(2):313-25
18539296
Am J Physiol Heart Circ Physiol. 2005 Jan;288(1):H365-70
15319210
J Pharmacol Exp Ther. 2008 Dec;327(3):602-9
18768779
Cardiovasc Res. 2004 Feb 15;61(3):372-85
14962470
Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9977-82
11493678
FASEB J. 2001 Jun;15(8):1454-6
11387255
J Biol Chem. 2009 Feb 20;284(8):5148-57
19103600
J Biol Chem. 2001 Jan 26;276(4):2571-5
11073947
Circ Res. 2003 Oct 17;93(8):697-9
14512440
Circ Res. 2010 Jul 23;107(2):171-85
20651294
Am J Physiol. 1999 Aug;277(2):H763-9
10444504
Circulation. 2008 Mar 4;117(9):1172-82
18285568
J Biol Chem. 1998 Feb 6;273(6):3611-7
9452489
Arch Biochem Biophys. 1979 Jul;195(2):468-77
112926
Am J Physiol. 1999 May;276(5):H1567-73
10330240
Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4891-6
12676984
Biochem J. 1999 Jul 15;341 ( Pt 2):233-49
10393078
Biochem J. 1995 Apr 1;307 ( Pt 1):93-8
7717999
Circ Res. 2009 Jan 2;104(1):41-9
19023128
J Biol Chem. 2003 Apr 25;278(17):15185-91
12576484
Circ Res. 2003 Nov 28;93(11):1074-81
14576200
Am J Physiol Heart Circ Physiol. 2002 Jun;282(6):H2422-6
12003854
J Mol Cell Cardiol. 1989 Dec;21(12):1241-51
2698962
EMBO J. 2000 Dec 1;19(23):6341-50
11101507
J Mol Cell Cardiol. 1994 Aug;26(8):995-1006
7799454
Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1711-9
19734355
Circ Res. 2001 Nov 9;89(10):891-8
11701616
Circ Res. 2000 Oct 27;87(9):812-7
11055986
Biochem Soc Trans. 2006 Apr;34(Pt 2):232-7
16545083
Am J Physiol Cell Physiol. 2008 Jun;294(6):C1509-20
18367586
Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):2059-64
11742885
J Mol Cell Cardiol. 2007 Jan;42(1):177-85
17069847
Circ Res. 1989 Apr;64(4):665-75
2702730
Am J Physiol Cell Physiol. 2007 Jan;292(1):C178-87
16899550
Am J Physiol Heart Circ Physiol. 2007 Sep;293(3):H1391-9
17573462
Arterioscler Thromb Vasc Biol. 1999 Nov;19(11):2776-81
10559025
Am J Physiol Heart Circ Physiol. 2003 Jan;284(1):H277-82
12485820
Circ Res. 2004 Nov 12;95(10):957-70
15539639
Circ Res. 2001 Jun 22;88(12):1267-75
11420303
Circulation. 2001 May 29;103(21):2598-603
11382730
Circulation. 1986 Dec;74(6):1424-33
3779923
Am J Physiol Cell Physiol. 2006 Jan;290(1):C57-65
16107505
Am J Physiol Heart Circ Physiol. 2001 Jul;281(1):H48-52
11406467
J Am Coll Cardiol. 2002 Sep 18;40(6):1172-8
12354446
Stroke. 2003 Jul;34(7):1796-802
12791941
Circulation. 2003 Nov 4;108(18):2275-81
14568900
Am J Physiol Heart Circ Physiol. 2000 Dec;279(6):H2824-8
11087237
Am J Med. 2000 Jun 1;108(8):652-9
10856414
Biochim Biophys Acta. 1998 Aug 10;1366(1-2):177-96
9714796
Am J Physiol. 1998 Nov;275(5):H1865-72
9815095
Circulation. 2004 Sep 14;110(11):e303; author reply e303
15364824